Galapagos NV
GLPG
#4564
Rank
HK$16.43 B
Marketcap
HK$245.81
Share price
-0.57%
Change (1 day)
17.98%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): -HK$2.52

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is -HK$2.64. In 2024 the company made an earnings per share (EPS) of HK$9.07 a decrease over its 2023 EPS that were of HK$27.61.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$2.52-127.79%
2024HK$9.07-67.16%
2023HK$27.61-199.64%
2022-HK$27.7199.03%
2021-HK$13.92-68.98%
2020-HK$44.89-298.06%
2019HK$22.66-554.64%
2018-HK$4.98-77.18%
2017-HK$21.85-326.21%
2016HK$9.66-134.19%
2015-HK$28.25-371.34%
2014HK$10.41-445.98%
2013-HK$3.0132.88%
2012-HK$2.26-82.07%
2011-HK$12.63-817.9%
2010HK$1.7612.73%
2009HK$1.56-120.79%
2008-HK$7.51-37.67%
2007-HK$12.0439.64%
2006-HK$8.6228.17%
2005-HK$6.736.25%
2004-HK$6.33

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
AstraZeneca
AZN
HK$23.62-994.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
HK$81.23-3,178.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$28.83-1,192.75%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
HK$10.52-498.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
-HK$11.44 333.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$62.69-2,475.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$4.90-285.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
HK$27.98-1,160.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
HK$59.09-2,339.29%๐Ÿ‡บ๐Ÿ‡ธ USA